Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03252847
Recruitment Status : Recruiting
First Posted : August 17, 2017
Last Update Posted : July 17, 2019
Sponsor:
Collaborators:
Syne Qua Non Limited
Bionical-Emas Pharma Ltd
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2020
  Estimated Study Completion Date : November 2020